Advent Health Ocala’s ICAM Protocol Takes on COVID-19: Clinician Drives Real World Evidence & Breakthrough: Physicians, nurses, and all healthcare workers have served heroically during this pandemic, not only in the U.S. but all over the world. Faced with a…
Armand Balboni, MD, PhD, JD, CEO of Appili Therapeutics, discusses progress toward FDA authorization and/or approval of favipiravir for COVID-19.
Mukesh Ambani-led Reliance Industries Ltd (RIL) recorded the highest value of transactions for a share ever on NSE yesterday; The legal profession, like many other sectors, will see disruptive change with 20 per cent of the routine legal works likely…
The pricing and limited supply of COVID-19 antivirals such as Remdesivir and Favipiravir may make them difficult or impossible for some people and countries to access. Roger Seheult, MD of discusses recent articles that highlight the limited supply of certain…
#covid19drugupdate #coronavirusdrugupdate #coronilkitpatanjali ==================== नमस्कार! 🙏 In this episode, we learn about Covid-19 Drug Update or Coronavirus Drug Update. A lot of efforts are being put in to find Covid-19 Drug and Vaccine and we are presenting here some Covid-19…
Glenmark’s FabiFlu approved for coronavirus treatment in India, costs Rs 103 per tablet Mumbai-based Glenmark Pharmaceuticals have launched a new antiviral drug – Favipiravir with brand name FabiFlu – for the treatment of mild to moderate Covid-19 patients. The firm…
